Search for Clinical Trial Results

Sponsored By

Exanthema - 21 Studies Found

Status Study
Completed Study Name: Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)
Condition: Polymorphic Light Eruption (PLE)
Date: 2007-05-10
Interventions: Drug: Afamelanotide (CUV1647) 16mg implant
Completed Study Name: Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer
Condition: Rash
Date: 2007-05-10
Interventions:
  • Drug: Minocycline Patients wil
Terminated Study Name: 1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX
Condition: Rash
Date: 2012-07-11
Interventions:
  • Drug: Pimecrolimus Pimecrolimu
Completed Study Name: Fluoride Varnish for Treatment of White Spot Lesions
Condition: White Spot Lesions
Date: 2011-12-22
Interventions:
  • Device: Vanish varnish 5% sodi
Completed Study Name: Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash
Condition: Acneiform Rash
Date: 2010-12-07
Interventions:
  • Drug: Threolone ointment ointm
Not yet recruiting Study Name: Effect of Curodont Repair on Color Change of White Spot Lesions
Condition: White Spot Lesion
Date: 2016-09-21
Interventions:
  • Drug: Curodont Repair composed
Active, not recruiting Study Name: Effect of CO2 Laser on Enamel White Spot Lesion Formation Around Orthodontic Brackets
Condition: White Spot Lesion
Date: 2017-04-11
Interventions:
  • Radiation: CO2 laser irradiation

Not yet recruiting Study Name: One Year Clinical Evaluation of White Spot Lesions Treated With Newly Introduced Resin Modified Glass Ionomer in Comparison to Resin Infiltration in Anterior Teeth Split Mouth Technique
Condition: White Spot Lesions
Date: 2016-09-20
Interventions:
  • Drug: Vanish xt Extended Contact Varnish

Completed Study Name: Remineralisation of White Spot Lesions by Elmex® gelée in Post-orthodontic Patients
Condition: Tooth; Lesion, White Spot Lesions
Date: 2011-04-01
Interventions:
  • Drug: elmex® gelée 1
Active, not recruiting Study Name: FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema
Condition: Colorectal Cancer Metastatic
Date: 2011-03-11
Interventions: Drug: FOLFIRI + Cetuximab

    • <<< Previous | Next >>>